Skip to main content
. 2022 Feb 18;322(4):H568–H574. doi: 10.1152/ajpheart.00019.2022

Table 1.

Participant characteristics

HA MDD P Value
n (men/women) 11 (6/5) 14 (4/10) 0.24
Body weight, kg 73 ± 19 64 ± 15 0.19
Height, cm 169.6 ± 13.6 166.7 ± 8.8 0.52
Body mass index, kg/m2 25.0 ± 3.0 22.8 ± 4.0 0.16
Total physical activity, min/day 231 ± 333 273 ± 203 0.71
Cardiovascular      
 SBP, mmHg 115 ± 11 114 ± 9 0.73
 DBP, mmHg 74 ± 7 74 ± 6 0.79
 MAP, mmHg 87 ± 8 87 ± 7 0.99
 HR, beats/min 76 ± 12 72 ± 10 0.36
Depression severity      
 PROMIS, raw score 15 ± 6 24 ± 6 0.0004*
 PROMIS, T score 52 ± 7 62 ± 6 0.0008*
 PHQ-9, AU 2 ± 2 9 ± 6 0.0013*
T cells
 %CD3+, lymphocytes 61 ± 12 67 ± 8 0.16
 %CD4+, CD3+ 50 ± 7 50 ± 11 0.87
 %CD8+, CD3+ 37 ± 5 34 ± 8 0.27
 CD4-to-CD8 ratio 1.38 ± 0.39 1.60 ± 0.69 0.36

Values are represented as means ± SD; n, number of participants. AU, arbitrary units; SBP, systolic blood pressure; DBP, diastolic blood pressure; HA, healthy nondepressed young adults; HR, heart rate; MAP, mean arterial pressure; MDD, major depressive disorder; PHQ-9, patient health questionnaire (symptom severity: 0–4, minimal; 5–9, mild; 10–14, moderate; 15–19, moderately severe; 20–27, severe); PROMIS, patient-reported outcome measurement information system; SBP, systolic blood pressure. All data, except sex ratios (Fisher’s exact test), were analyzed using Student’s unpaired sample t test. *P < 0.05, significantly greater in MDD compared with HA.